| Bioactivity | BTK-IN-14 is a potent inhibitor of BTK. BTK plays an important role in signaling mediated by B cell antigen receptor (BCR) and Fcγreceptor (FcγR) in B cells and myeloid cells, respectively. BTK-IN-14 has the potential for the research of related diseases, especially autoimmune diseases, inflammatory diseases or cancer (extracted from patent WO2022057894A1, compound 1)[1]. |
| Name | BTK-IN-14 |
| CAS | 2764674-60-2 |
| Formula | C38H44N8O4 |
| Molar Mass | 676.81 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Guangxiu Dai, et al. Heteroaryl heterocyclic compounds and uses thereof. Patent WO2022057894A1. |
BTK-IN-14
CAS: 2764674-60-2 F: C38H44N8O4 W: 676.81
BTK-IN-14 is a potent inhibitor of BTK. BTK plays an important role in signaling mediated by B cell antigen receptor (BC
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.